Annual CFI
$75.30 K
+$285.20 K+135.87%
01 June 2024
Summary:
Genetic Technologies Limited annual cash flow from investing activities is currently $75.30 thousand, with the most recent change of +$285.20 thousand (+135.87%) on 01 June 2024. During the last 3 years, it has risen by +$634.20 thousand (+113.47%). GENE annual CFI is now -98.46% below its all-time high of $4.88 million, reached on 30 June 2002.GENE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$16.80 K
-$55.50 K-76.76%
01 June 2024
Summary:
Genetic Technologies Limited quarterly cash flow from investing activities is currently $16.80 thousand, with the most recent change of -$55.50 thousand (-76.76%) on 01 June 2024. Over the past year, it has dropped by -$55.50 thousand (-76.76%). GENE quarterly CFI is now -99.97% below its all-time high of $66.47 million, reached on 01 March 2005.GENE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$89.10 K
+$206.80 K+175.70%
01 June 2024
Summary:
Genetic Technologies Limited TTM cash flow from investing activities is currently $89.10 thousand, with the most recent change of +$206.80 thousand (+175.70%) on 01 June 2024. Over the past year, it has increased by +$206.80 thousand (+175.70%). GENE TTM CFI is now -99.87% below its all-time high of $66.47 million, reached on 01 March 2005.GENE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GENE Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +135.9% | -76.8% | +175.7% |
| 3 y3 years | +113.5% | +115.3% | +118.2% |
| 5 y5 years | +120.1% | - | - |
GENE Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +103.0% | -76.8% | +108.8% | at high | +118.2% |
| 5 y | 5 years | at high | +103.0% | -76.8% | +104.4% | at high | +118.2% |
| alltime | all time | -98.5% | +103.0% | -100.0% | +104.4% | -99.9% | +118.2% |
Genetic Technologies Limited Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | $75.30 K(-135.9%) | $16.80 K(-76.8%) | $89.10 K(-175.7%) |
| Dec 2023 | - | $72.30 K(-138.1%) | -$117.70 K(-5.8%) |
| June 2023 | -$209.90 K(-91.6%) | -$190.00 K(-392.3%) | -$125.00 K(-258.2%) |
| Dec 2022 | - | $65.00 K(+364.3%) | $79.00 K(+34.8%) |
| June 2022 | -$2.51 M(+349.0%) | $14.00 K(-68.6%) | $58.60 K(-190.2%) |
| Dec 2021 | - | $44.60 K(-140.7%) | -$65.00 K(-86.7%) |
| June 2021 | -$558.90 K(-1384.8%) | -$109.60 K(-71.2%) | -$489.60 K(+28.8%) |
| Dec 2020 | - | -$380.00 K | -$380.00 K |
| June 2020 | $43.50 K(-111.6%) | - | - |
| June 2019 | -$375.10 K(-3888.9%) | - | - |
| June 2018 | $9900.00(-109.2%) | - | - |
| June 2017 | -$108.10 K(-49.9%) | - | - |
| June 2016 | -$215.80 K(-113.1%) | - | - |
| June 2015 | $1.65 M(+671.4%) | - | - |
| June 2014 | $213.30 K(-216.2%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | -$183.50 K(-136.1%) | - | - |
| June 2012 | $507.70 K(>+9900.0%) | - | - |
| June 2011 | $5000.00(-100.5%) | - | - |
| June 2010 | -$916.80 K(+247.8%) | - | - |
| June 2009 | -$263.60 K(+520.2%) | - | - |
| June 2008 | -$42.50 K(-132.8%) | - | - |
| June 2007 | $129.40 K(-210.8%) | - | - |
| June 2006 | -$116.80 K(+514.7%) | - | - |
| June 2005 | -$19.00 K(-97.1%) | - | - |
| Mar 2005 | - | $66.47 M | $66.47 M |
| June 2004 | -$654.00 K(+334.3%) | - | - |
| June 2003 | -$150.60 K(-103.1%) | - | - |
| June 2002 | $4.88 M(+473.8%) | - | - |
| June 2001 | $851.00 K(+53.3%) | - | - |
| June 2000 | $555.00 K | - | - |
FAQ
- What is Genetic Technologies Limited annual cash flow from investing activities?
- What is the all time high annual CFI for Genetic Technologies Limited?
- What is Genetic Technologies Limited annual CFI year-on-year change?
- What is Genetic Technologies Limited quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Genetic Technologies Limited?
- What is Genetic Technologies Limited quarterly CFI year-on-year change?
- What is Genetic Technologies Limited TTM cash flow from investing activities?
- What is the all time high TTM CFI for Genetic Technologies Limited?
- What is Genetic Technologies Limited TTM CFI year-on-year change?
What is Genetic Technologies Limited annual cash flow from investing activities?
The current annual CFI of GENE is $75.30 K
What is the all time high annual CFI for Genetic Technologies Limited?
Genetic Technologies Limited all-time high annual cash flow from investing activities is $4.88 M
What is Genetic Technologies Limited annual CFI year-on-year change?
Over the past year, GENE annual cash flow from investing activities has changed by +$285.20 K (+135.87%)
What is Genetic Technologies Limited quarterly cash flow from investing activities?
The current quarterly CFI of GENE is $16.80 K
What is the all time high quarterly CFI for Genetic Technologies Limited?
Genetic Technologies Limited all-time high quarterly cash flow from investing activities is $66.47 M
What is Genetic Technologies Limited quarterly CFI year-on-year change?
Over the past year, GENE quarterly cash flow from investing activities has changed by -$55.50 K (-76.76%)
What is Genetic Technologies Limited TTM cash flow from investing activities?
The current TTM CFI of GENE is $89.10 K
What is the all time high TTM CFI for Genetic Technologies Limited?
Genetic Technologies Limited all-time high TTM cash flow from investing activities is $66.47 M
What is Genetic Technologies Limited TTM CFI year-on-year change?
Over the past year, GENE TTM cash flow from investing activities has changed by +$206.80 K (+175.70%)